Midazolam 전투약이 목표농도 조절방식으로 투여되는 Propofol과 Rocuronium 작용 발현에 미치는 영향

Background: This clinical study was designed to evaluate the effect of midazolam as a premedication on the onset of propofol and rocuronium during propofol target-controlled infusion (TCI). Methods: Seventy four patients (ASA class I or II) were randomly allocated to receive either no premedication...

Full description

Saved in:
Bibliographic Details
Published inKorean journal of anesthesiology Vol. 57; no. 4; pp. 434 - 437
Main Authors 구의경, Eui Kyoung Goo, 정철희, Cheol Hee Jung, 김환희, Hwan Hee Kim, 소윤미, Yun Mi So, 나효석, Hyo Seok Na, 박희평, Hee Pyoung Park, 전영태, Young Tae Jeon, 황정원, Jung Won Hwang
Format Journal Article
LanguageKorean
Published 대한마취통증의학회 30.10.2009
Subjects
Online AccessGet full text
ISSN2005-6419
2005-7563

Cover

Abstract Background: This clinical study was designed to evaluate the effect of midazolam as a premedication on the onset of propofol and rocuronium during propofol target-controlled infusion (TCI). Methods: Seventy four patients (ASA class I or II) were randomly allocated to receive either no premedication (control group) or premedication with 0.04 mg/kg intravenous midazolam (midazolam group). Anesthesia was induced and maintained with propofol TCI. Time from propofol injection to loss of consciousness (LOC) and estimated effect concentration at LOC were recorded. After LOC, rocuronium (0.6 mg/kg) was injected. We monitored the degree of neuromuscular blockade by acceleromyography. The following parameters were measured and compared between groups: Time from rocuronium injection to depression of twitch height below 25%, time to maximal depression of twitch height (defined as rocuronium onset time). Results: Systolic blood pressure before induction was lower in midazolam group (125±15 vs 135±20 mmHg), however, there was no difference in blood pressure at LOC between groups (111±16 vs 106±21 mmHg). In midazolam group, time to LOC in propofol TCI was shorter (63±22 vs. 203±118 sec) and estimated effect site concentration of propofol was significantly lower than control group (0.9±0.3 vs. 2.2±0.4 μl/ml). The onset time of rocuronium was not different between groups (120±39 vs. 137±42 sec). Conclusions: Midazolam pretreatment fastens the onset time of propofol and decreases the propofol requirement for LOC. However, it does not influence the onset of rocuronium. (Korean J Anesthesiol 2009;57:434∼7)
AbstractList Background: This clinical study was designed to evaluate the effect of midazolam as a premedication on the onset of propofol and rocuronium during propofol target-controlled infusion (TCI). Methods: Seventy four patients (ASA class I or II) were randomly allocated to receive either no premedication (control group) or premedication with 0.04 mg/kg intravenous midazolam (midazolam group). Anesthesia was induced and maintained with propofol TCI. Time from propofol injection to loss of consciousness (LOC) and estimated effect concentration at LOC were recorded. After LOC, rocuronium (0.6 mg/kg) was injected. We monitored the degree of neuromuscular blockade by acceleromyography. The following parameters were measured and compared between groups: Time from rocuronium injection to depression of twitch height below 25%, time to maximal depression of twitch height (defined as rocuronium onset time). Results: Systolic blood pressure before induction was lower in midazolam group (125 ± 15 vs 135 ± 20 mmHg), however, there was no difference in blood pressure at LOC between groups (111 ± 16 vs 106 ± 21 mmHg). In midazolam group, time to LOC in propofol TCI was shorter (63 ± 22 vs. 203 ± 118 sec) and estimated effect site concentration of propofol was significantly lower than control group (0.9 ± 0.3 vs. 2.2 ± 0.4μl/ml). The onset time of rocuronium was not different between groups (120 ± 39 vs. 137 ± 42 sec). Conclusions: Midazolam pretreatment fastens the onset time of propofol and decreases the propofol requirement for LOC. However, it does not influence the onset of rocuronium. Background: This clinical study was designed to evaluate the effect of midazolam as a premedication on the onset of propofol and rocuronium during propofol target-controlled infusion (TCI). Methods: Seventy four patients (ASA class I or II) were randomly allocated to receive either no premedication (control group) or premedication with 0.04 mg/kg intravenous midazolam (midazolam group). Anesthesia was induced and maintained with propofol TCI. Time from propofol injection to loss of consciousness (LOC) and estimated effect concentration at LOC were recorded. After LOC, rocuronium (0.6 mg/kg) was injected. We monitored the degree of neuromuscular blockade by acceleromyography. The following parameters were measured and compared between groups: Time from rocuronium injection to depression of twitch height below 25%, time to maximal depression of twitch height (defined as rocuronium onset time). Results: Systolic blood pressure before induction was lower in midazolam group (125 ± 15 vs 135 ± 20 mmHg), however, there was no difference in blood pressure at LOC between groups (111 ± 16 vs 106 ± 21 mmHg). In midazolam group, time to LOC in propofol TCI was shorter (63 ± 22 vs. 203 ± 118 sec) and estimated effect site concentration of propofol was significantly lower than control group (0.9 ± 0.3 vs. 2.2 ± 0.4μl/ml). The onset time of rocuronium was not different between groups (120 ± 39 vs. 137 ± 42 sec). Conclusions: Midazolam pretreatment fastens the onset time of propofol and decreases the propofol requirement for LOC. However, it does not influence the onset of rocuronium. KCI Citation Count: 0
Background: This clinical study was designed to evaluate the effect of midazolam as a premedication on the onset of propofol and rocuronium during propofol target-controlled infusion (TCI). Methods: Seventy four patients (ASA class I or II) were randomly allocated to receive either no premedication (control group) or premedication with 0.04 mg/kg intravenous midazolam (midazolam group). Anesthesia was induced and maintained with propofol TCI. Time from propofol injection to loss of consciousness (LOC) and estimated effect concentration at LOC were recorded. After LOC, rocuronium (0.6 mg/kg) was injected. We monitored the degree of neuromuscular blockade by acceleromyography. The following parameters were measured and compared between groups: Time from rocuronium injection to depression of twitch height below 25%, time to maximal depression of twitch height (defined as rocuronium onset time). Results: Systolic blood pressure before induction was lower in midazolam group (125±15 vs 135±20 mmHg), however, there was no difference in blood pressure at LOC between groups (111±16 vs 106±21 mmHg). In midazolam group, time to LOC in propofol TCI was shorter (63±22 vs. 203±118 sec) and estimated effect site concentration of propofol was significantly lower than control group (0.9±0.3 vs. 2.2±0.4 μl/ml). The onset time of rocuronium was not different between groups (120±39 vs. 137±42 sec). Conclusions: Midazolam pretreatment fastens the onset time of propofol and decreases the propofol requirement for LOC. However, it does not influence the onset of rocuronium. (Korean J Anesthesiol 2009;57:434∼7)
Author Hyo Seok Na
Jung Won Hwang
Cheol Hee Jung
정철희
Hwan Hee Kim
박희평
소윤미
Hee Pyoung Park
구의경
Young Tae Jeon
전영태
황정원
Yun Mi So
김환희
나효석
Eui Kyoung Goo
Author_xml – sequence: 1
  fullname: 구의경
– sequence: 2
  fullname: Eui Kyoung Goo
– sequence: 3
  fullname: 정철희
– sequence: 4
  fullname: Cheol Hee Jung
– sequence: 5
  fullname: 김환희
– sequence: 6
  fullname: Hwan Hee Kim
– sequence: 7
  fullname: 소윤미
– sequence: 8
  fullname: Yun Mi So
– sequence: 9
  fullname: 나효석
– sequence: 10
  fullname: Hyo Seok Na
– sequence: 11
  fullname: 박희평
– sequence: 12
  fullname: Hee Pyoung Park
– sequence: 13
  fullname: 전영태
– sequence: 14
  fullname: Young Tae Jeon
– sequence: 15
  fullname: 황정원
– sequence: 16
  fullname: Jung Won Hwang
BackLink https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001385596$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNotjE1LAkEAhpcwyMxf0GWOXRZmZndm16NIH4JRmPdl9sNYVh3ZxUPRJZCIIlKolFhDDx0MIaEOBfaHmtn_kKmn5z0877OppBq84a0paQwhUQ1CtdRqUx3lNpRsFPk2JNDQdMPEaeXi0HfZOa-xOpDDdnI9kY8_cvAJxNs46cbi6k7ct4EcTeXwWkzH8nYg45kYxeDf7E1Epy9uHsBxyJu8ymu_HzNQ5k4r5A2_NQ--dOXzGIhpnPTbstcB4v1Lfi8esn-ZPL1uKetVVou87IoZ5WRvt1I4UEtH-8VCvqQGBiEqcj03h3VEXQJNYjJsMGLrhocd4mBPYybC1LQN5mjIdGwXQeQ6FDLkMmjayNMyys6y2girVuD4Fmf-gqfcCkIrX64ULQNTTMlc3V6qgR9FVjP06yw8s7CJIKVY-wN-EIW7
ContentType Journal Article
DBID HZB
Q5X
ACYCR
DatabaseName KISS(한국학술정보)
Korean Studies Information Service System (KISS) B-Type
Korean Citation Index
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Midazolam 전투약이 목표농도 조절방식으로 투여되는 Propofol과 Rocuronium 작용 발현에 미치는 영향
Effect of midazolam premedication on the onset of propofol and rocuronium during propofol target-controlled infusion
EISSN 2005-7563
EndPage 437
ExternalDocumentID oai_kci_go_kr_ARTI_726265
2810662
GroupedDBID 5-W
53G
8JR
8XY
9ZL
ALMA_UNASSIGNED_HOLDINGS
EF.
F5P
GROUPED_DOAJ
HZB
Q5X
ABDBF
ACUHS
ACYCR
ADRAZ
DIK
E3Z
EBD
ESX
HYE
KQ8
M48
O5R
O5S
OK1
PGMZT
RPM
TUS
ID FETCH-LOGICAL-k755-1ded92416d50858a27a5b47e2c5c2e3a81268b7ac318cbd101dc60a1da08b1e3
ISSN 2005-6419
IngestDate Sun Mar 09 07:51:04 EDT 2025
Fri Dec 20 02:16:25 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Language Korean
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-k755-1ded92416d50858a27a5b47e2c5c2e3a81268b7ac318cbd101dc60a1da08b1e3
Notes The Korean Society of Anesthesiologists
G704-000679.2009.57.4.003
PageCount 4
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_726265
kiss_primary_2810662
PublicationCentury 2000
PublicationDate 20091030
PublicationDateYYYYMMDD 2009-10-30
PublicationDate_xml – month: 10
  year: 2009
  text: 20091030
  day: 30
PublicationDecade 2000
PublicationTitle Korean journal of anesthesiology
PublicationTitleAlternate Korean Journal of Anesthesiology
PublicationYear 2009
Publisher 대한마취통증의학회
Publisher_xml – name: 대한마취통증의학회
SSID ssib050734782
ssib038074859
ssj0000330062
Score 1.7585644
Snippet Background: This clinical study was designed to evaluate the effect of midazolam as a premedication on the onset of propofol and rocuronium during propofol...
SourceID nrf
kiss
SourceType Open Website
Publisher
StartPage 434
SubjectTerms Midazolam
Propofol
Rocuronium
Target-controlled infusion
마취과학
Title Midazolam 전투약이 목표농도 조절방식으로 투여되는 Propofol과 Rocuronium 작용 발현에 미치는 영향
URI https://kiss.kstudy.com/ExternalLink/Ar?key=2810662
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001385596
Volume 57
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Korean Journal of Anesthesiology, 2009, 57(4), , pp.434-437
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ : Directory of Open Access Journals [open access]
  customDbUrl:
  eissn: 2005-7563
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000330062
  issn: 2005-6419
  databaseCode: DOA
  dateStart: 19680101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2005-7563
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib050734782
  issn: 2005-6419
  databaseCode: M~E
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 2005-7563
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000330062
  issn: 2005-6419
  databaseCode: 5-W
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Na9RANLQ9eRGlivWLCM4prORrJpNjkt1aW-pBKxQvS75Wl9WmbLsHiwhCkaKILagtspX24KFSsKAHhfqHTPY_-N4k2Q_owXrJTt7Oe_Pmvcy895KZN5J009QagcX8oKLqoVExTbVR4TSOK4xSzkON8YZIkjR_l808MGcX6eLY-MOhVUud1eBWuHbivpL_0SrAQK-4S_YUmu0TBQCUQb9wBQ3D9Z90PN-M_DWITZ8qpOYRRyXcJLUq4Zw4HkJsStyqKFSJa0IllzgOcWysZGvE9hDCGeFVUZgG_JySRly1JMnxP7hFNI9wF4khSY-4At9BQspou5YoQFWV2AKfO8Q2cVfCctJInpCaQ1wD8JV7SdjB7LydvAt2DfnCArKpFC0jn1UkhN0T1G0178w0cTmCXHukHVELqmsCjxGHDvvgc0m7_PxQuOI-zPfgCK80R74xCC5p2SXBAEJ0kGk_Duk0lblnOGEqt5NkgCgkB9JH1nQsIx9VMshz6T2OE8zqHCuzncJ3KF-92MJmqf3BIrrl4YoUJEILrTmW0AzQB1lzIX2G3GLTrFRRznOOlSvdAVKDuV8kiGVmYU0KQ5Vn8i4GpDlkdcziffBo4nCda5jef1wahzkdF7W-qJUzLZ4yYPKBIwtBgWGW5xoIH8YwcHctnsxYcgI-C4Q0K-CDLbUbQz7YwjnpbBE8yU4-Es5LY61kUnreHwVytrfe2zjMPvzOdn_I6deD3lY3ffU2fbcuZ_tH2d5GenSQvdnNusfpflfGmtuH6eZO-vq9XD6Zf74fy4NnUs4-b2WfDuT0qNvbWc-2N-X028_sl8DIdl72Pn65IN2fri14M5XiTJFKy6K0okVxZIPTyiIITCj3dcungWnFekhDPTZ8cHcZDyw_BFMXBhHYqyhkqq9FvsoDLTYuShNLyVJ8SZL1sKFhsj2mhtQELD_WIp1pPLZjI1Qb0ZQ0ieKqL-dJY-qFNqakGyC-eits1jGxO_4-Suqtdh3C1zt1S2c6o5dPRr0inRk8hFelidV2J74GHvFqcF0o9y-ULqS2
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Midazolam+%EC%A0%84%ED%88%AC%EC%95%BD%EC%9D%B4+%EB%AA%A9%ED%91%9C%EB%86%8D%EB%8F%84+%EC%A1%B0%EC%A0%88%EB%B0%A9%EC%8B%9D%EC%9C%BC%EB%A1%9C+%ED%88%AC%EC%97%AC%EB%90%98%EB%8A%94+Propofol%EA%B3%BC+Rocuronium+%EC%9E%91%EC%9A%A9+%EB%B0%9C%ED%98%84%EC%97%90+%EB%AF%B8%EC%B9%98%EB%8A%94+%EC%98%81%ED%96%A5&rft.jtitle=Korean+journal+of+anesthesiology&rft.au=%EA%B5%AC%EC%9D%98%EA%B2%BD&rft.au=Eui+Kyoung+Goo&rft.au=%EC%A0%95%EC%B2%A0%ED%9D%AC&rft.au=Cheol+Hee+Jung&rft.date=2009-10-30&rft.pub=%EB%8C%80%ED%95%9C%EB%A7%88%EC%B7%A8%ED%86%B5%EC%A6%9D%EC%9D%98%ED%95%99%ED%9A%8C&rft.issn=2005-6419&rft.volume=57&rft.issue=4&rft.spage=434&rft.externalDocID=2810662
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2005-6419&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2005-6419&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2005-6419&client=summon